These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3128656)
1. A novel antitumor cyclic hexapeptide (RA-700) obtained from Rubiae radix. Hamanaka T; Ohgoshi M; Kawahara K; Yamakawa K; Tsuruo T; Tsukagoshi S J Pharmacobiodyn; 1987 Nov; 10(11):616-23. PubMed ID: 3128656 [TBL] [Abstract][Full Text] [Related]
2. Cell growth-inhibitory effects of derivatives of antitumor cyclic hexapeptide RA-V obtained from Rubiae radix (V). Itokawa H; Takeya K; Mori N; Takanashi M; Yamamoto H; Sonobe T; Kidokoro S Gan; 1984 Oct; 75(10):929-36. PubMed ID: 6510638 [TBL] [Abstract][Full Text] [Related]
3. Studies on antitumor cyclic hexapeptides RA obtained from Rubiae Radix, Rubiaceae. III. On derivatives of RA-V and their in vivo activities. Itokawa H; Takeya K; Mori N; Sonobe T; Serisawa N; Hamanaka T; Mihashi S Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):3216-26. PubMed ID: 6518600 [No Abstract] [Full Text] [Related]
4. Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems. Imai R; Morimoto M; Marumo H; Kobayashi T; Tsuruo T; Inaba M; Tsukagoshi S; Sakurai Y Gan; 1981 Dec; 72(6):944-9. PubMed ID: 6804296 [TBL] [Abstract][Full Text] [Related]
5. Preparation and cytotoxicity of cyclic hexapeptides, RA derivatives. Itokawa H; Kondo K; Hitotsuyanagi Y; Nakamura A; Morita H; Takeya K Chem Pharm Bull (Tokyo); 1993 Jul; 41(7):1266-9. PubMed ID: 8374996 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152). Fujimoto K; Oka T; Morimoto M Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218 [TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo. Tsuruo T; Sudo Y; Asami N; Inaba M; Morimoto M Cancer Chemother Pharmacol; 1990; 27(2):89-93. PubMed ID: 2123421 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of mitomycin C-dextran conjugate against various murine tumors. Hashida M; Kato A; Kojima T; Muranishi S; Sezaki H; Tanigawa N; Satomura K; Hikasa Y Gan; 1981 Apr; 72(2):226-34. PubMed ID: 6169584 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C. Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076 [TBL] [Abstract][Full Text] [Related]
10. Studies on antitumor cyclic hexapeptides RA obtained from rubiae radix, rubiaceae. VI. Minor antitumor constituents. Itokawa H; Takeya K; Mori N; Sonobe T; Mihashi S; Hamanaka T Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3762-8. PubMed ID: 3815597 [No Abstract] [Full Text] [Related]
11. Studies on antitumour cyclic hexapeptides RA obtained from Rubiae radix, Rubiaceae (IV): Quantitative determination of RA-VII and RA-V in commercial Rubiae radix and collected plants. Itokawa H; Takeya K; Mori N; Kidokoro S; Yamamoto H Planta Med; 1984 Aug; 50(4):313-6. PubMed ID: 6505082 [No Abstract] [Full Text] [Related]
12. Antitumor activity and toxicity in mice of RA-700, a cyclic hexapeptide. Kato T; Suzumura Y; Takamoto S; Ota K Anticancer Res; 1987; 7(3 Pt B):329-34. PubMed ID: 3631886 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of 7-N-phenyl derivatives of mitomycin C in the leukemia P388 system. Imai R; Ashizawa T; Urakawa C; Morimoto M; Nakamura N Gan; 1980 Aug; 71(4):560-2. PubMed ID: 7437130 [TBL] [Abstract][Full Text] [Related]
14. Activity of RA-700, a cyclic hexapeptide from Rubiae Radix, in the human tumor clonogenic assay. Inoue K; Mukaiyama T; Kobayashi T; Ogawa M Invest New Drugs; 1986; 4(3):231-6. PubMed ID: 3818226 [TBL] [Abstract][Full Text] [Related]
15. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan. Sato M; Onishi H; Takahara J; Machida Y; Nagai T Biol Pharm Bull; 1996 Sep; 19(9):1170-7. PubMed ID: 8889036 [TBL] [Abstract][Full Text] [Related]
16. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799 [TBL] [Abstract][Full Text] [Related]
17. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate. Mabel JA; Wodinsky I Cancer; 1983 Feb; 51(4):600-5. PubMed ID: 6401590 [TBL] [Abstract][Full Text] [Related]
18. Per-N-methylated analogues of an antitumor bicyclic hexapeptide RA-VII. Hitotsuyanagi Y; Lee JE; Kato S; Kim IH; Kohashi H; Fukaya H; Takeya K Bioorg Med Chem; 2011 Apr; 19(7):2458-63. PubMed ID: 21382716 [TBL] [Abstract][Full Text] [Related]
19. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid. Kruczynski A; Colpaert F; Tarayre JP; Mouillard P; Fahy J; Hill BT Cancer Chemother Pharmacol; 1998; 41(6):437-47. PubMed ID: 9554586 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity and toxicity in animals of RR-150 (7-cysteaminomitosane), a new mitomycin derivative. Bradner WT; Rose WC; Schurig JE; Schlein A; Huftalen JB Cancer Res; 1984 Dec; 44(12 Pt 1):5619-23. PubMed ID: 6437670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]